Evaluation of the NCCLS extended-spectrum β-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3142-3146

  Tenover, Fred C ^a   Raney, Patti M ^a   Williams, Portia P ^b   Rasheed, J Kamile ^a   Biddle, James W ^a   Oliver, Antonio ^c   Fridkin, Scott K ^a   Jevitt, Laura ^a   McGowan Jr , John E ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; ESCHERICHIA COLI; EVALUATION; ISOELECTRIC POINT; LABORATORY DIAGNOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS; CLAVULANIC ACID; ESCHERICHIA COLI; HUMANS; ISOELECTRIC FOCUSING; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0038168181     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3142-3146.2003     Document Type: Article

References (32)

1. Archibald, L., L. Phillips, D. Monnet, J. E. McGowan, Jr., F. Tenover, and R. Gaynes. 1997. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: the increasing importance of the intensive care unit. Clin. Infect. Dis. 24:211-215.
2. Bopp, C. A., F. W. Brenner, J. G. Wells, and N. A. Strockbine. 1999. Escherichia, Shigella, and Salmonella, p. 459-474. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
3. Bou, G., A. Oliver, M. Ojeda, C. Monzon, and J. Martinez-Beltran. 2000. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated β-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob. Agents Chemother. 44:2549-2553.
4. Bradford, P. A. 2001. Extended-spectrum β-lactamases. Clin. Microbiol. Rev. 14:933-951.
5. Bret, L., C. Chanal-Claris, D. Sirot, E. B. Chaibi, R. Labia, and J. Sirot. 1998. Chromosomally encoded AmpC-type β-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 42:1110-1114.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of β-lactamases from Gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84.
8. Caroff, N., E. Espaze, I. Bérard, H. Richet, and A. Reynaud. 1999. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production. FEMS Microbiol. Lett. 173:459-465.
9. Centers for Disease Control and Prevention. 2000. Laboratory capacity to detect antimicrobial resistance, 1998. Morb. Mortal. Wkly. Rep. 48:1167-1171.
10. Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans Medical Center. J. Clin. Microbiol. 38:1791-1796.
11. Fridkin, S. K., C. D. Steward, J. R. Edwards, E. R. Pryor, J. E. McGowan, Jr., L. K. Archibald, R. P. Gaynes, F. C. Tenover, and Project Intensive Care Antimicrobial Resistance Epidemiology Hospitals. 1999. Surveillance of antimicrobial use and antimicrobial resistance in U.S. hospitals: Project ICARE Phase 2. Clin. Infect. Dis. 29:245-252.
12. Galleni, M., F. Lindberg, S. Normark, S. Cole, S. Honore, B. Joris, and J. Frère. 1988. Sequence and comparative analysis of three Enterobacter cloacae ampC β-lactamase genes and their product. Biochem. J. 250:753-760.
13. Lindberg, F., and S. Normark. 1986. Sequence of the Citrobacter freundii OS60 chromosomal AmpC β-lactamase gene. Eur. J. Biochem. 156:441-445.
14. Livermore, D. M. 1995. β-Lactamases in the clinical laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
15. Mabilat, C., and S. Goussard. 1993. PCR detection and identification of genes for extended-spectrum β-lactamases, p. 553-559. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
16. Mallea, M., J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Regli, C. Bollet, and J. M. Pages. 1998. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144:3003-3009.
17. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical iso-electric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
18. Mazzariol, A., G. Cornaglia, and H. Nikaido. 2000. Contributions of the AmpC β-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to β-lactams. Antimicrob. Agents Chemother. 44:1387-1390.
19. Naas, T., and P. Nordmann. 1999. OXA-type β-lactamases. Curr. Pharm. Des. 5:865-879.
20. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility tests. Approved standard - 7th ed.; M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard M100-S10. National Committee for Clinical Laboratory Standards, Wayne, Pa.
23. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Nelson, E. C., and B. G. Elisha. 1999. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43:957-959.
25. Neu, H. C. 1982. The new beta-lactamase-stable cephalosporins. Ann. Intern. Med. 97:408-419.
26. Oliver, A., L. M. Weigel, J. K. Rasheed, J. E. McGowan, Jr., and F. C. Tenover. 2002. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli. Antimicrob. Agents Chemother. 46:3829-3836.
27. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
28. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
29. Steward, C. D., J. K. Rasheed, S. K. Hubert, J. W. Biddle, P. M. Raney, G. J. Anderson, P. P. Williams, K. L. Brittain, A. Oliver, J. E. McGowan, Jr., and F. C. Tenover. 2001. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods. J. Clin. Microbiol. 39:2864-2872.
30. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
31. Tenover, F. C., J. M. Mohammed, T. S. Gorton, and Z. F. Dembeck. 1999. Detection and reporting of organisms producing extended-spectrum β-lactamases: a survey of laboratories in Connecticut. J. Clin. Microbiol. 37:4065-4070.
32. Tzouvelekis, L. S., E. Tzelepi, P. T. Tassios, and N. J. Legakis. 2000. CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int. J. Antimicrob. Agents 14:137-142.